Grapevine: PE-backed Sekhmet in fray for Glenmark's arm; Easebuzz to raise fresh funding

By Staff Writer

  • 12 Jun 2023
Premium
Credit: 123RF.com

Gamot API-operated active pharma ingredient platform Sekhmet Pharmaventures is in the fray with Ahmedabad-based Nirma Group for acquisition of Glenmark Pharma’s subsidiary, said a media report, citing several people aware of the development.   Sekhmet, backed by the likes of PAG, CX Partners and Samara Capital is also likely to have ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.